ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. SMD Rise PCL's annualizedNet Income for the quarter that ended in Mar. 2026 was ฿-122.2 Mil.
SMD Rise PCL's average Total Assets over the quarter that ended in Mar. 2026 was ฿1,393.3 Mil. Therefore, SMD Rise PCL's annualized ROA % for the quarter that ended in Mar. 2026 was -8.77%.
The historical rank and industry rank for SMD Rise PCL's ROA % or its related term are showing as below:
BKK:SMD100-R'
s ROA % Range Over the Past 10 Years
Min: 0.5 Med: 12.96 Max: 31.69
Current: 0.5
During the past 8 years, SMD Rise PCL's highest ROA % was 31.69%. The lowest was 0.50%. And the median was 12.96%.
BKK:SMD100-R's ROA % is ranked worse than 71.67% of 120
companies
in the Medical Distribution industry
Industry Median: 2.23
vs BKK:SMD100-R: 0.50
SMD Rise PCL (BKK:SMD100-R) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
SMD Rise PCL ROA % Related Terms
SMD Rise PCL ROA % Historical Data
* Premium members only.
The historical data trend for SMD Rise PCL's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, SMD Rise PCL's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SMD Rise PCL ROA % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, SMD Rise PCL's ROA % distribution charts can be found below:
* The bar in red indicates where SMD Rise PCL's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
SMD Rise PCL (BKK:SMD100-R) has a ROA % of -8.77% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on SMD Rise PCL and its competitors. Over the past decade, SMD Rise PCL's ROA % has ranged from 0.50 to 31.69. According to the industry distribution chart, SMD Rise PCL ranks #86 out of 120 companies in the Medical Distribution industry, placing it in the top 71.7%.
Is SMD Rise PCL's ROA % too high?
SMD Rise PCL's current ROA % is -8.77%. Over the past 10 years, this metric has ranged from a low of 0.50 to a high of 31.69. Based on the distribution chart, SMD Rise PCL ranks #86 out of 120 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, SMD Rise PCL has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does SMD Rise PCL's ROA % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, SMD Rise PCL ranks #86 out of 120 companies for ROA %. This places SMD Rise PCL in the lower half of its industry. The industry median ROA % is 2.23. Historically, SMD Rise PCL's own ROA % has ranged from 0.50 to 31.69 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Distribution company?
The median ROA % among Medical Distribution companies is 2.23, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on SMD Rise PCL and its competitors. For the Medical Distribution industry, the median ROA % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SMD Rise PCL's current ROA % is -8.77%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SMD Rise PCL stock overvalued right now?
SMD Rise PCL (BKK:SMD100-R) has a current ROA % of -8.77%. The stock's GF Value™ is ฿23.66, compared to a current price of ฿5.85 — trading 75.3% below its estimated fair value. The current ROA % is -8.77%. SMD Rise PCL's overall GF Score™ is 59/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For SMD Rise PCL (BKK:SMD100-R), the current ROA % is -8.77% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SMD Rise PCL (BKK:SMD100-R) Overvalued in 2026?
Based on GuruFocus' analysis, SMD Rise PCL stock appears to be undervalued.
The current stock price of ฿5.85 is trading 75.3% below its estimated GF Value™ of ฿23.66.
Key valuation signals for BKK:SMD100-R:
ROA %: -8.77%
GF Value™: ฿23.66 vs. price of ฿5.85 (75.3% below fair value)
No single metric tells the full story. See the BKK:SMD100-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Address222,222/1-2 Moo 1, Rattanathibet Road, West Inn Complex Building, 10th Floor, Bang Rak Yai Subdistrict, Bang Bua Thong District, Nonthaburi Province, Bangkok, THA, 11110
SMD Rise PCL, formerly Saintmed PCL is engaged in the import and distribution of medical devices and equipment, rental services for medical equipment, and providing services related to medical equipment. It operates in Thailand. The Group is engaged in three operating segments: Sale of medical devices and equipment, medical supplies, Services of medical equipment at sleep lab centers and repair services, and Revenue from rental of medical equipment at wellness centers and other services. The Group is managed and operates principally in Thailand.
59GF Score
Get the complete analysis for BKK:SMD100-R
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:SMD100-R has been successfully added to your 
